Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1699315

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Medical Treatments
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made, in each of the past five years, of the economic costs of the effects of post-operative cancer treatments.
	tabling member printed	Lord Wills
	uin	HL3712
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>The Department is working jointly with NHS England and Cancer Alliances to ensure every person receives personalised care and support from cancer diagnosis onwards, including post-treatment. As outlined in the NHS Long Term Plan for cancer, where appropriate, every person diagnosed with cancer will have access to personalised care, including needs assessment, a care plan and health and wellbeing information and support. After treatment, the person will move to a follow-up pathway that suits their needs, and ensures they can get rapid access to clinical support, where they are worried that their cancer may have recurred.</p><p>Post-operative cancer treatments encompass a wide variety of care, depending on the type and stage of cancer, the treatment the patient has had, and the patient’s needs. Follow-up care often includes regular check-ups, blood tests, scans, and procedures. It may also involve further treatments to deal with late and long-term side effects, including chemotherapy or radiotherapy to reduce the risk of cancer coming back. These highly individualised treatments have varying economic costs.</p> answering member printed Lord Markham question first answered 05/04/2024 13:26:44 answering member 4948 label Biography information for Lord Markham
	tabling member	260 label Biography information for Lord Wills

1699327

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Population
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of the impact on the UK of the global decline in fertility rates.
	tabling member printed	Lord Farmer
	uin	HL3671
	answer	answer is ministerial correction date of answer 10/04/2024 answer text <p>No such assessment has been made.</p> answering member printed Lord Markham question first answered 10/04/2024 12:43:43 answering member 4948 label Biography information for Lord Markham
	tabling member	4321 label Biography information for Lord Farmer

1699328

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Birth Rate
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of the impact of the Abortion Act 1967 on UK birth rates.
	tabling member printed	Lord Farmer
	uin	HL3672
	answer	answer is ministerial correction date of answer 10/04/2024 answer text <p>No assessment has been made of the impact of the Abortion Act 1967 on United Kingdom birth rates. Parliament decided the circumstances under which abortion can legally be undertaken. Under the act, women have access to safe, legal, regulated abortion services.</p> answering member printed Lord Markham question first answered 10/04/2024 11:07:17 answering member 4948 label Biography information for Lord Markham
	tabling member	4321 label Biography information for Lord Farmer

1699329

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health: Boys
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what action they are taking to help the mental health of boys who were impacted by the lockdown restrictions.
	tabling member printed	Lord Farmer
	uin	HL3673
	answer	answer is ministerial correction date of answer 10/04/2024 answer text <p>We want to ensure that all children and young people get the mental health support they need, including boys.</p><p>By the end of 2023/24 the overall spending on mental health has increased by more than £4.7 billion in cash terms since 2018/19 (before the COVID-19 lockdown restrictions were introduced).</p><p>There are now around 400 mental health support teams in place across England, covering 3.4 million children or around 35% of pupils in schools and colleges. We estimate this will increase to 44% by April 2024 and we are working to increase this coverage to 50% of pupils by March 2025.</p><p>There are also currently around 65 locally funded early support hubs in England. These hubs are open to those aged 11 to 25 years old and, importantly, they are for anyone who may not meet the threshold to receive National Health Service support. Following a competitive commercial process from hubs across the country, the government is now providing up to £8 million to 24 existing hubs to provide even more support. This means children and young people, including boys, who are experiencing feelings of anxiety or stress will have a physical space to go to in their community when their problems first emerge, without the need for a referral.</p> answering member printed Lord Markham question first answered 10/04/2024 11:07:05 answering member 4948 label Biography information for Lord Markham
	tabling member	4321 label Biography information for Lord Farmer

1699316

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Equipment: Storage
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 9 February (HL2216), why the information mentioned in the Answer on government expenditure is commercially sensitive.
	tabling member printed	Baroness Wolf of Dulwich
	uin	HL3713
	answer	answer is ministerial correction date of answer 09/04/2024 answer text <p>At the time of answering, the Department was engaged in commercial negotiations with NHS Supply Chain and their sub-contractors, relating to ongoing storage requirements for the COVID Strategic Intensive Care Unit. In December 2023, the average per pallet per week cost for equipment in the COVID Strategic Intensive Care Unit was £5.52.</p><p>The Department currently makes payments to NHS Supply Chain in relation to storage of personal protective equipment (PPE). At end of December 2023 there were 492,259 pallets, or 5.1 billion items, of COVID-19 PPE remining in storage. This includes both business as usual and excess stock.</p> answering member printed Lord Markham question first answered 09/04/2024 13:31:41 answering member 4948 label Biography information for Lord Markham
	tabling member	4347 label Biography information for Baroness Wolf of Dulwich

1699274

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Physician Associates
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 25 March (HL2978), why they have specified how physician associates (PAs) are to be used, specifically with undifferentiated patients, rather than allowing GP practices to make their own decisions about the use of PAs.
	tabling member printed	Baroness Bennett of Manor Castle
	uin	HL3652
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>Physician Associates (PAs) work within a defined scope of practice and limits of competence. NHS England has provided recent guidance on the use of PAs in general practice (GP) teams. As set out in the Network Contract Directed Enhanced Service, PAs should be adequately supervised by a GP when providing care for undifferentiated patients.</p><p>In terms of employment choices, GPs are self-employed contractors to the National Health Service, and it is largely up to employers to determine how best to staff their primary care network or GP, to best meet the needs of their population.</p> answering member printed Lord Markham question first answered 05/04/2024 13:32:33 answering member 4948 label Biography information for Lord Markham
	tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1698924

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Greater Manchester: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when she last met with Greater Manchester NHS Board to discuss the statutory commissioning of NICE approved medicines.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	20611
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.</p><p>The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.</p><p>The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE’s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20612 20613 question first answered 15/04/2024 08:04:14 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4034 label Biography information for Yvonne Fovargue

1698925

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Greater Manchester: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions NHS England have had with Greater Manchester NHS on their statutory responsibilities to commission NICE approved medicines.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	20612
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.</p><p>The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.</p><p>The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE’s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20611 20613 question first answered 15/04/2024 08:04:14 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4034 label Biography information for Yvonne Fovargue

1698926

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what guidance her Department issues NHS trusts on establishing commissioning structures for Health Technology Assessments; and whether trusts have discretion to adopt different processes.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	20613
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.</p><p>The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.</p><p>The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE’s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20611 20612 question first answered 15/04/2024 08:04:14 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4034 label Biography information for Yvonne Fovargue

1699117

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Autism and Learning Disability: Housing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to enable adults with (a) learning disabilities and (b) autism living in in-patient units to live independently.
	tabling member constituency	Lewisham, Deptford
	tabling member printed	Vicky Foxcroft
	uin	20712
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>We are taking action to support timely discharges of people with a learning disability and autistic people from mental health inpatient services, and to support them in leading ordinary lives in their communities. In January 2024, we published guidance which sets out key principles for how National Health Service bodies and local authorities should work together to support people to be discharged from mental health inpatient services.</p><p>To improve community support, in 2023/24 we invested an additional £121 million as part of the NHS Long Term Plan, including funding for children and young people’s keyworkers. The Building the Right Support Action Plan, published in July 2022, sets out cross-Government actions to strengthen community support and reduce reliance on mental health inpatient care for people with a learning disability and autistic people.</p><p>As set out in NHS England statutory guidance published on 9 May 2023, we expect integrated care boards to assign an executive lead role for learning disability and autism to a suitable board member. The named lead will support the board in planning to meet the needs of its local population of autistic people and people with a learning disability.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 15/04/2024 08:49:53 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4491 label Biography information for Vicky Foxcroft